Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0100
+0.0020 (25.00%)
May 24, 2024, 4:00 PM EDT - Market closed

Baudax Bio Revenue

Baudax Bio had revenue of $310.00K in the twelve months ending September 30, 2023, down -22.50% year-over-year. In the year 2022, Baudax Bio had annual revenue of $1.27M with 17.50% growth.

Revenue (ttm)
$310.00K
Revenue Growth
-22.50%
P/S Ratio
0.26
Revenue / Employee
$34,444
Employees
9
Market Cap
79.94K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20221.27M189.00K17.50%
Dec 31, 20211.08M587.00K119.07%
Dec 31, 2020493.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings